Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Pfizer Beat Competitors to TB Cure?
Wall St. Cheat Sheet
Friday, October 19, 2012 - 11:03am
tags:
Pfizer, tuberculosis, linezolid
Biogen Says Its FDA Delay Unrelated To Abbott's Failed Medicine
Forbes
Friday, October 19, 2012 - 11:02am
tags:
FDA, MS, Biogen Idec, Abbott Labs, BG-12, Bardoxolone
Vertex Draws Collaboration Interest For Hepatitis C Combo
Bloomberg
Friday, October 19, 2012 - 11:01am
tags:
Vertex Pharmaceuticals, VX-135, hepatitis C
Processing Aegerion Pharmaceuticals' Recent Rally
Seeking Alpha
Friday, October 19, 2012 - 10:57am
tags:
Aegerion, lomitapide, Homozygous Familial Hypercholesterolemia
BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment
Yahoo/Fly on the Wall
Thursday, October 18, 2012 - 1:10pm
tags:
Biocryst, Presidio, hepatitis C, M&A, Gilead, Abbott Labs, Achillion
What Does Wall Street See for Questcor Pharmaceuticals's Q3?
Motley Fool
Thursday, October 18, 2012 - 1:08pm
tags:
Questcor Pharmaceuticals
BioTime makes offer for Geron stem cell assets
Yahoo/AP
Thursday, October 18, 2012 - 1:07pm
tags:
Geron, stem cells, M&A, BioTime
Amgen Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thursday, October 18, 2012 - 1:06pm
tags:
earnings, Amgen
Abbott adds 550 to layoffs toll as split-up nears
Fierce Pharma
Thursday, October 18, 2012 - 12:53pm
tags:
layoffs, Abbott Labs, AbbVie
An FDA Decision Is on the MAP
Motley Fool
Thursday, October 18, 2012 - 12:50pm
tags:
FDA, MAP Pharmaceuticals, Levadex, migraines
Amarin strength attributed to pervious comments in peer review journal
Yahoo/Fly on the Wall
Thursday, October 18, 2012 - 12:48pm
tags:
Amarin
Novavax shares rocket on preliminary results for experimental bird flu vaccine
Yahoo/AP
Thursday, October 18, 2012 - 11:57am
tags:
Novavax, bird flu, vaccines
Merck & Co and Theravance sign $153 million cardio pact
Pharma Times, UK
Thursday, October 18, 2012 - 11:56am
tags:
Merck, Theravance
Review of Biogen Idec's MS Drug Delayed
Minyanville
Thursday, October 18, 2012 - 11:44am
tags:
MS, multiple sclerosis, Biogen Idec, FDA, BG-12
Pfizer Settles First Chantix Suicide Case Set for Trial
Bloomberg
Thursday, October 18, 2012 - 11:43am
tags:
Pfizer, Chantix, smoking cessation
Abbott, Reata kidney disease drug trial stopped
Reuters
Thursday, October 18, 2012 - 11:42am
tags:
Abbott, Reata, kidney disease, Bardoxolone, AbbVie, Humira
Isis Pharma/Genzyme FDA Panel Live Blog
TheStreet.com
Thursday, October 18, 2012 - 11:39am
tags:
Genzyme, FDA, Sanofi, Isis Pharmaceuticals, advisory panels, Aegerion, Homozygous Familial Hypercholesterolemia, mipomersen
Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?
Seeking Alpha
Thursday, October 18, 2012 - 11:37am
tags:
Ampio, Humira, Remicade, Enbrel, Celebrex, anti-inflammatories, Abbott Labs, Amgen, Ampion, JNJ, Pfizer
Drug showed promise in clearing drug-resistant tuberculosis
Reuters
Thursday, October 18, 2012 - 11:35am
tags:
tuberculosis, Pfizer, Zyvox
Cyclacel Heats Up On Clinical Trial Progression
Seeking Alpha
Wednesday, October 17, 2012 - 11:56am
tags:
Cyclacel, Sapacitabine, myelodysplastic syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.